|
시장보고서
상품코드
1566792
피부 충전제 시장 : 유형별, 성별, 서비스 제공업체별 - 세계 기회 분석 및 산업 예측(2024-2033년)Dermal Filler Market By Type (Hyaluronic acid , Calcium Hydroxylapatite , Poly L lactic Acid, Others), By Gender By Service Provider : Global Opportunity Analysis and Industry Forecast, 2024-2033 |
||||||
피부 충전제 시장
피부 충전제 시장은 2023년 63억 달러로 평가되며 2024-2033년 연평균 10.3% 성장하여 2033년에는 168억 달러에 달할 것으로 예상됩니다.
피부 충전제는 피부에 주입하여 피부의 볼륨을 회복하고, 주름과 주름을 부드럽게 하고, 얼굴의 윤곽을 강조하기 위해 피부에 주입하는 젤 형태의 물질입니다. 피부 충전제 주입은 비수술적 과정이며, 주입된 필러의 종류에 따라 즉각적인 효과가 나타나며 몇 개월에서 몇 년 동안 지속됩니다. 히알루론산은 피부에 수분을 공급하고 볼륨을 부여하는 데 사용되는 피부 충전제의 가장 일반적인 성분입니다. 합성 필러와는 별도로, 사람의 다른 신체 부위에서 채취한 지방을 원하는 신체 부위에 주입하는 자연적 형태의 피부 충전제도 있습니다. 이 과정은 자가 지방 이식이라는 용어로 알려져 있습니다.
조기 노화 증상의 발생은 피부 충전제 시장의 주요 촉진요인 중 하나입니다. 또한, 소셜 미디어의 영향으로 개인, 특히 여성의 미의식이 높아지면서 피부 충전제에 대한 수요가 증가하고 있습니다. 최근에는 생체 자극 필러가 체내 천연 콜라겐 생성을 촉진하기 때문에 개인들 사이에서 인기를 끌고 있습니다. 이러한 필러는 신체의 자연적인 재생 과정을 촉진하기 때문에 화학적 필러와 비교할 수 없습니다.
그러나 피부 충전제 주사를 투여하는 비용은 상당히 높기 때문에 많은 사람들이 그 이점을 활용하지 못하고 있습니다. 또한 시술 후 합병증과 부작용은 일부 개인에게 매우 해로울 수 있으므로 일부 개인은 그러한 주사를 투여하는 것을 꺼려합니다. 부작용의 가능성에도 불구하고 피부 충전제의 사례는 해마다 증가하고 있습니다. 국제미용성형외과학회는 2023년 전 세계 외과적 및 비외과적 미용성형수술의 통계를 파악하기 위한 조사를 실시했습니다. 이 조사에 따르면 히알루론산 필러의 경우 2023년에 29% 증가할 것이며, 피부 충전제의 경우 미국에서 가장 큰 것으로 나타났습니다.
부문 리뷰
세계 피부 충전제 시장은 유형, 성별, 서비스 제공업체, 지역별로 분류됩니다. 유형별로는 히알루론산(HA), 칼슘하이드록실아파타이트(CaHA), 폴리L-락트산, 기타로 나뉩니다. 성별로는 남성과 여성으로 나뉩니다. 서비스 제공자별로는 전문 및 피부과 클리닉, 병원, 기타로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카로 분석됩니다.
주요 조사 결과
유형별로는 히알루론산(HA) 부문이 2023년 시장에서 가장 큰 수익을 창출했습니다.
성별로는 여성 부문이 2023년 피부 충전제 시장을 장악했습니다.
서비스 제공자별로는 병원 부문이 2023년 가장 큰 이해관계자로 나타났습니다.
지역별로는 북미가 2023년 가장 높은 수익을 올렸습니다.
본 보고서의 커스터마이징 가능성(추가 비용 및 일정이 필요합니다.)
- 규제 가이드라인
- 고객의 관심사에 따른 기업 프로파일 추가
- 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
- 기업 개요 확대 목록
- 과거 시장 데이터
- 주요 진입기업 세부 정보(위치, 연락처, 공급업체/벤더 네트워크 등 포함, 엑셀 형식)
목차
제1장 소개
제2장 주요 요약
제3장 시장 상황
- 시장 정의와 범위
- 주요 조사 결과
- 주요 투자 기회
- 주요 성공 전략
- Porter's Five Forces 분석
- 시장 역학
- 성장 촉진요인
- 성장 억제요인
- 기회
제4장 피부 충전제 시장 : 유형별
- 시장 개요
- 히알루론산(HA)
- 연령층
- 13-39세
- 40-54세
- 55-69세
- 연령층
- 칼슘 하이드록시아파타이트(CaHA)
- 폴리 L 젖산
- 기타
제5장 피부 충전재 시장 : 성별
- 시장 개요
- 남성
- 여성
제6장 피부 충전제 시장 : 서비스 프로바이더별
- 시장 개요
- 전문 클리닉과 피부과 클리닉
- 병원
- 기타
제7장 피부 충전제 시장 : 지역별
- 시장 개요
- 북미
- 주요 시장 동향과 기회
- 미국의 피부 충전제 시장
- 캐나다의 피부 충전제 시장
- 멕시코의 피부 충전제 시장
- 유럽
- 주요 시장 동향과 기회
- 독일의 피부 충전제 시장
- 프랑스의 피부 충전제 시장
- 영국의 피부 충전제 시장
- 이탈리아의 피부 충전제 시장
- 스페인의 피부 충전제 시장
- 기타 유럽의 피부 충전제 시장
- 아시아태평양
- 주요 시장 동향과 기회
- 일본의 피부 충전제 시장
- 중국의 피부 충전제 시장
- 인도의 피부 충전제 시장
- 호주의 피부 충전제 시장
- 한국의 피부 충전제 시장
- 기타 아시아태평양의 피부 충전제 시장
- 라틴아메리카, 중동 및 아프리카
- 주요 시장 동향과 기회
- 브라질의 피부 충전제 시장
- 사우디아라비아의 피부 충전제 시장
- 남아프리카공화국의 피부 충전제 시장
- 기타 라틴아메리카, 중동 및 아프리카의 피부 충전제 시장
제8장 경쟁 상황
- 소개
- 주요 성공 전략
- 주요 10개 기업 제품 매핑
- 경쟁 대시보드
- 경쟁 히트맵
- 주요 기업의 포지셔닝(2023년)
제9장 기업 개요
- Teoxane Laboratories
- Cutera Inc
- Elan Aesthetics Inc
- Bioxis Pharmaceutical
- AbbVie Laboratories
- Sinclair Pharma
- Sosum Global
- Revance Therapeutics
- Galderma SA
- Merz Pharma
Dermal Filler Market
The dermal filler market was valued at $6.3 billion in 2023, and is projected to reach $16.8 billion by 2033, growing at a CAGR of 10.3% from 2024 to 2033.
Dermal filler is a gel-like substance injected into the skin to restore its volume, smooth out its lines & wrinkles, and enhance the contours of the face. The injection of derma fillers is a non-surgical process which shows instant results and lasts for a few months to years, depending on the type of filler injected. Hyaluronic acid is the most common component of derma fillers used to hydrate and volumize the skin. Apart from synthetic fillers, there is a natural form of derma filler where fat from some other body part of a person is injected into the target body part. This process is known by the term - autologous fat grafting.
Rise in occurrence of ageing symptoms at an early stage is one of the major drivers of the dermal filler market. Moreover, increase in aesthetic awareness among individuals, particular females, due the influence of social media is boosting the demand for dermal fillers. In recent times, biostimulatory fillers are acquiring traction among individuals as they promote the production of natural collagen in the body. These fillers promote the natural regenerative process inside the body, hence are not comparable to chemical fillers.
However, the expenses of administering dermal filler injections are significantly high, which prevent a large population from availing the benefits. In addition, the post-procedure complications and side-effects are highly adverse in some individuals, hence making several individuals reluctant about administering such injections. Despite the chances of side effects, the cases of dermal fillers are increasing every year. The International Society of Aesthetic Plastic Surgery conducted a survey in 2023 to determine the statistics of surgical and non-surgical cosmetic procedures around the globe. According to this survey, named, International Survey on Aesthetic/Cosmetic Procedures, the cases of hyaluronic acid fillers upsurged by 29% in 2023, with maximum derma filler cases occurring in the U.S.
Segment Review
The global dermal filler market is segmented into type, gender, service provider, and region. On the basis of type, the market is divided into hyaluronic acid (HA), calcium hydroxylapatite (CaHA), poly L lactic acid, and others. By gender, it is bifurcated into male and female. Depending on service provider, it is classified into specialty & dermatology clinics, hospitals, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of type, the hyaluronic acid (HA) segment generated the largest revenue in the market in 2023.
By gender, the female segment dominated the dermal fillers market in 2023.
Depending on service provider, the hospitals segment was the largest stakeholder in 2023.
Region wise, North America was the highest revenue generator in 2023.
Competition Analysis
The major players operating in the global dermal filler market are Teoxane Laboratories, Cutera Inc, Elan aesthetics Inc, Bioxis pharmaceutical, AbbVie Laboratories, Sinclair Pharma, Sosum Global, Revance Therapeutics, Galderma SA, and Merz Pharma. These players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Type
- Hyaluronic acid (HA)
- Age group
◦ 13 to 39
◦ 40 to 54
◦ 55 to 69
- Calcium Hydroxylapatite (CaHA)
- Poly L lactic Acid
- Others
By Gender
- Male
- Female
By Service Provider
- Specialty and Dermatology Clinics
- Hospitals
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players:
- Teoxane Laboratories
- Cutera Inc
- Elan aesthetics Inc
- Bioxis pharmaceutical
- AbbVie Laboratories
- Sinclair Pharma
- Sosum Global
- Revance Therapeutics
- Galderma SA
- Merz Pharma
TABLE OF CONTENTS
CHAPTER 1: INTRODUCTION
- 1.1. Report Description
- 1.2. Key Market Segments
- 1.3. Key Benefits
- 1.4. Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
- 2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
- 3.1. Market Definition and Scope
- 3.2. Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
- 3.3. Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
- 3.4. Market Dynamics
- 3.4.1. Drivers
- 3.4.2. Restraints
- 3.4.3. Opportunities
CHAPTER 4: DERMAL FILLER MARKET, BY TYPE
- 4.1. Market Overview
- 4.1.1 Market Size and Forecast, By Type
- 4.2. Hyaluronic Acid (HA)
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
- 4.2.5. Age group
- 4.2.5.1. Market Size and Forecast
- 4.2.5.2. 13 to 39
- 4.2.5.2.1. Market Size and Forecast
- 4.2.5.2. 40 to 54
- 4.2.5.2.1. Market Size and Forecast
- 4.2.5.2. 55 to 69
- 4.2.5.2.1. Market Size and Forecast
- 4.3. Calcium Hydroxylapatite (CaHA)
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country
- 4.4. Poly L Lactic Acid
- 4.4.1. Key Market Trends, Growth Factors and Opportunities
- 4.4.2. Market Size and Forecast, By Region
- 4.4.3. Market Share Analysis, By Country
- 4.5. Others
- 4.5.1. Key Market Trends, Growth Factors and Opportunities
- 4.5.2. Market Size and Forecast, By Region
- 4.5.3. Market Share Analysis, By Country
CHAPTER 5: DERMAL FILLER MARKET, BY GENDER
- 5.1. Market Overview
- 5.1.1 Market Size and Forecast, By Gender
- 5.2. Male
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
- 5.3. Female
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
CHAPTER 6: DERMAL FILLER MARKET, BY SERVICE PROVIDER
- 6.1. Market Overview
- 6.1.1 Market Size and Forecast, By Service Provider
- 6.2. Specialty And Dermatology Clinics
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
- 6.3. Hospitals
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
- 6.4. Others
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
CHAPTER 7: DERMAL FILLER MARKET, BY REGION
- 7.1. Market Overview
- 7.1.1 Market Size and Forecast, By Region
- 7.2. North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Type
- 7.2.3. Market Size and Forecast, By Gender
- 7.2.4. Market Size and Forecast, By Service Provider
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.S. Dermal Filler Market
- 7.2.6.1. Market Size and Forecast, By Type
- 7.2.6.2. Market Size and Forecast, By Gender
- 7.2.6.3. Market Size and Forecast, By Service Provider
- 7.2.7. Canada Dermal Filler Market
- 7.2.7.1. Market Size and Forecast, By Type
- 7.2.7.2. Market Size and Forecast, By Gender
- 7.2.7.3. Market Size and Forecast, By Service Provider
- 7.2.8. Mexico Dermal Filler Market
- 7.2.8.1. Market Size and Forecast, By Type
- 7.2.8.2. Market Size and Forecast, By Gender
- 7.2.8.3. Market Size and Forecast, By Service Provider
- 7.3. Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Type
- 7.3.3. Market Size and Forecast, By Gender
- 7.3.4. Market Size and Forecast, By Service Provider
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Dermal Filler Market
- 7.3.6.1. Market Size and Forecast, By Type
- 7.3.6.2. Market Size and Forecast, By Gender
- 7.3.6.3. Market Size and Forecast, By Service Provider
- 7.3.7. France Dermal Filler Market
- 7.3.7.1. Market Size and Forecast, By Type
- 7.3.7.2. Market Size and Forecast, By Gender
- 7.3.7.3. Market Size and Forecast, By Service Provider
- 7.3.8. UK Dermal Filler Market
- 7.3.8.1. Market Size and Forecast, By Type
- 7.3.8.2. Market Size and Forecast, By Gender
- 7.3.8.3. Market Size and Forecast, By Service Provider
- 7.3.9. Italy Dermal Filler Market
- 7.3.9.1. Market Size and Forecast, By Type
- 7.3.9.2. Market Size and Forecast, By Gender
- 7.3.9.3. Market Size and Forecast, By Service Provider
- 7.3.10. Spain Dermal Filler Market
- 7.3.10.1. Market Size and Forecast, By Type
- 7.3.10.2. Market Size and Forecast, By Gender
- 7.3.10.3. Market Size and Forecast, By Service Provider
- 7.3.11. Rest of Europe Dermal Filler Market
- 7.3.11.1. Market Size and Forecast, By Type
- 7.3.11.2. Market Size and Forecast, By Gender
- 7.3.11.3. Market Size and Forecast, By Service Provider
- 7.4. Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Type
- 7.4.3. Market Size and Forecast, By Gender
- 7.4.4. Market Size and Forecast, By Service Provider
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Dermal Filler Market
- 7.4.6.1. Market Size and Forecast, By Type
- 7.4.6.2. Market Size and Forecast, By Gender
- 7.4.6.3. Market Size and Forecast, By Service Provider
- 7.4.7. China Dermal Filler Market
- 7.4.7.1. Market Size and Forecast, By Type
- 7.4.7.2. Market Size and Forecast, By Gender
- 7.4.7.3. Market Size and Forecast, By Service Provider
- 7.4.8. India Dermal Filler Market
- 7.4.8.1. Market Size and Forecast, By Type
- 7.4.8.2. Market Size and Forecast, By Gender
- 7.4.8.3. Market Size and Forecast, By Service Provider
- 7.4.9. Australia Dermal Filler Market
- 7.4.9.1. Market Size and Forecast, By Type
- 7.4.9.2. Market Size and Forecast, By Gender
- 7.4.9.3. Market Size and Forecast, By Service Provider
- 7.4.10. South Korea Dermal Filler Market
- 7.4.10.1. Market Size and Forecast, By Type
- 7.4.10.2. Market Size and Forecast, By Gender
- 7.4.10.3. Market Size and Forecast, By Service Provider
- 7.4.11. Rest of Asia-Pacific Dermal Filler Market
- 7.4.11.1. Market Size and Forecast, By Type
- 7.4.11.2. Market Size and Forecast, By Gender
- 7.4.11.3. Market Size and Forecast, By Service Provider
- 7.5. LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Type
- 7.5.3. Market Size and Forecast, By Gender
- 7.5.4. Market Size and Forecast, By Service Provider
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Dermal Filler Market
- 7.5.6.1. Market Size and Forecast, By Type
- 7.5.6.2. Market Size and Forecast, By Gender
- 7.5.6.3. Market Size and Forecast, By Service Provider
- 7.5.7. Saudi Arabia Dermal Filler Market
- 7.5.7.1. Market Size and Forecast, By Type
- 7.5.7.2. Market Size and Forecast, By Gender
- 7.5.7.3. Market Size and Forecast, By Service Provider
- 7.5.8. South Africa Dermal Filler Market
- 7.5.8.1. Market Size and Forecast, By Type
- 7.5.8.2. Market Size and Forecast, By Gender
- 7.5.8.3. Market Size and Forecast, By Service Provider
- 7.5.9. Rest of LAMEA Dermal Filler Market
- 7.5.9.1. Market Size and Forecast, By Type
- 7.5.9.2. Market Size and Forecast, By Gender
- 7.5.9.3. Market Size and Forecast, By Service Provider
CHAPTER 8: COMPETITIVE LANDSCAPE
- 8.1. Introduction
- 8.2. Top Winning Strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
- 9.1. Teoxane Laboratories
- 9.1.1. Company Overview
- 9.1.2. Key Executives
- 9.1.3. Company Snapshot
- 9.1.4. Operating Business Segments
- 9.1.5. Product Portfolio
- 9.1.6. Business Performance
- 9.1.7. Key Strategic Moves and Developments
- 9.2. Cutera Inc
- 9.2.1. Company Overview
- 9.2.2. Key Executives
- 9.2.3. Company Snapshot
- 9.2.4. Operating Business Segments
- 9.2.5. Product Portfolio
- 9.2.6. Business Performance
- 9.2.7. Key Strategic Moves and Developments
- 9.3. Elan Aesthetics Inc
- 9.3.1. Company Overview
- 9.3.2. Key Executives
- 9.3.3. Company Snapshot
- 9.3.4. Operating Business Segments
- 9.3.5. Product Portfolio
- 9.3.6. Business Performance
- 9.3.7. Key Strategic Moves and Developments
- 9.4. Bioxis Pharmaceutical
- 9.4.1. Company Overview
- 9.4.2. Key Executives
- 9.4.3. Company Snapshot
- 9.4.4. Operating Business Segments
- 9.4.5. Product Portfolio
- 9.4.6. Business Performance
- 9.4.7. Key Strategic Moves and Developments
- 9.5. AbbVie Laboratories
- 9.5.1. Company Overview
- 9.5.2. Key Executives
- 9.5.3. Company Snapshot
- 9.5.4. Operating Business Segments
- 9.5.5. Product Portfolio
- 9.5.6. Business Performance
- 9.5.7. Key Strategic Moves and Developments
- 9.6. Sinclair Pharma
- 9.6.1. Company Overview
- 9.6.2. Key Executives
- 9.6.3. Company Snapshot
- 9.6.4. Operating Business Segments
- 9.6.5. Product Portfolio
- 9.6.6. Business Performance
- 9.6.7. Key Strategic Moves and Developments
- 9.7. Sosum Global
- 9.7.1. Company Overview
- 9.7.2. Key Executives
- 9.7.3. Company Snapshot
- 9.7.4. Operating Business Segments
- 9.7.5. Product Portfolio
- 9.7.6. Business Performance
- 9.7.7. Key Strategic Moves and Developments
- 9.8. Revance Therapeutics
- 9.8.1. Company Overview
- 9.8.2. Key Executives
- 9.8.3. Company Snapshot
- 9.8.4. Operating Business Segments
- 9.8.5. Product Portfolio
- 9.8.6. Business Performance
- 9.8.7. Key Strategic Moves and Developments
- 9.9. Galderma SA
- 9.9.1. Company Overview
- 9.9.2. Key Executives
- 9.9.3. Company Snapshot
- 9.9.4. Operating Business Segments
- 9.9.5. Product Portfolio
- 9.9.6. Business Performance
- 9.9.7. Key Strategic Moves and Developments
- 9.10. Merz Pharma
- 9.10.1. Company Overview
- 9.10.2. Key Executives
- 9.10.3. Company Snapshot
- 9.10.4. Operating Business Segments
- 9.10.5. Product Portfolio
- 9.10.6. Business Performance
- 9.10.7. Key Strategic Moves and Developments
